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Summary
Objectives: The aim of this study was to analyze changes in the extent of radiographic lesions
with treatment in patients with pulmonary tuberculosis (TB) and, further, to identify clinical and
radiographic factors related to radiographic response.
Methods: A prospective cohort study including patients with culture-proven pulmonary TB was
performed. The posterior-anterior view films of the chest that had been taken at the time of
diagnosis and at 6 months after the initiation of treatment were compared. We expressed the
extents of the lesions as percentages involving the parenchyma compared with the remaining
normal parenchyma.
Results: Among 135 patients enrolled, three failed to achieve smear conversion of sputa after 6
months of treatment. The extent of radiographic lesions decreased from 22.8% at the time of
diagnosis to 10.5% after 6 months of treatment. Through the multiple regression model, we found
that increasing age (p = 0.034), previous history of TB ( p = 0.016), presence of cavity (p = 0.016)
or fibrotic lesion ( p = 0.009), and multidrug-resistant TB (p = 0.002) were significantly associated
with a poor radiographic response.
Conclusion: Patients with less-prominent radiographic improvement and sustained negative
tuberculous cultures of the sputa could be closely observed without ordering unnecessary chest
radiographs or mycobacterial cultures as well as prolonging treatment.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Fax: +82 2 762 9662.
E-mail address: yimjj@snu.ac.kr (J.-J. Yim).
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Although the definite diagnosis of pulmonary tuberculosis
(TB) is based on culture of Mycobacterium tuberculosis, a
simple chest radiograph is a useful tool when applied as
part of a systemic approach in the evaluation of thosePublished by Elsevier Ltd. All rights reserved.
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their role in diagnosis, serial radiographs are preferred by
many physicians in monitoring treatment response, espe-
cially among patients who can no longer expectorate
sputum. However, this can be misleading for assessing
the progress and outcome of treatment because of the
wide spectrum of radiographic responses among TB
patients under treatment.1,4 This confusion often leads
many physicians to order unnecessary chest radiographs
or mycobacterial cultures as well as to prolong treatment
unnecessarily.
The aim of this study was to analyze changes in the extent
of radiographic lesions with treatment in patients with pul-
monary TB and, further, to identify clinical and radiographic
factors related to radiographic response.
Methods
Participants
A prospective cohort study including patients with culture-
proven pulmonary TB visiting a TB clinic at Seoul National
University Hospital, a tertiary referral hospital, from Sep-
tember 2002 to June 2006 was performed. Patients who
agreed to participate in the study were followed up on a
monthly basis. TB patients without definite parenchymal
lesions on a simple chest radiograph (chest posterior-ante-
rior view) were excluded from the study. We also excluded
patients who missed a scheduled visit more than once or
who were transferred out before the completion of anti-TB
medication. Patients who were found to be HIV-seroposi-
tive were also excluded from the study. Anti-TB drugs and
doses were selected according to the guidelines of the
American Thoracic Society.3 Treatment was based on a
daily self-administered therapy because direct observation
of ingestion of anti-TB drugs is not included in the national
TB control policy of Korea.5 The protocol of the current
study was approved by the ethical review committee of our
institution.
Evaluation of radiographs
Radiologists participating in this study were blind to clinical
and laboratory findings. All radiographic evaluations were
performed on the posterior-anterior view of the chest. Par-
enchymal lesions were classified by a board-certified radi-
ologist (Dr Chun). The extents of lesions were measured
separately by two board-certified radiologists (Drs Chun
and Lee) and the mean values of the two measurements
were used for the final analysis.
Classification of parenchymal lesions
Pulmonary parenchymal lesions were classified into mass-like
(>3 cm), nodules (<3 cm) with patchy opacity, fibrotic,
cavitary, linear, and miliary pattern, based on our previous
report.6 In addition, the multiplicity of the parenchymal
lesions was evaluated and they were categorized as single
or multiple lesions.
Extent of pulmonary lesions
To decide the extent of TB lesions, we divided the lung into
four areas including the right upper, right lower, left upper,and left lower lung fields in the posterior-anterior view of
the chest. In each field, we expressed the extent of the
lesion as the percentage involving the parenchyma com-
pared with the remaining normal parenchyma. We then
defined the extent of the lesions as the average of the
percentages from all four areas. Changes in radiographic
pulmonary lesions were calculated based on the comparison
of two films: chest radiographs taken before and at 6 months
after the initiation of anti-TB medication regardless of
treatment period.
Statistical analysis
The dependant variable was the change (as a continuous
variable) in extent of TB lesions, expressed as a percentage,
before and at 6 months after the initiation of anti-TB
medication. To identify the predictors of change in radio-
graphic extent, univariate analyses were performed using
the Student’s t-test, analysis of variance (ANOVA), a Mann—
Whitney U-test, or Kruskal—Wallis test for categorical inde-
pendent variables and a simple regression analysis for
continuous independent variables. Independent variables
analyzed included demographic characteristics, laboratory
results, and radiographic patterns. Variables with a p value
of <0.2 in the univariate analysis were screened for a
multiple regression model in order to identify the predic-
tors of radiographic improvement. In multiple regressions,
backward elimination was used to select variables to be
maintained in the final model, using a p value of <0.05 as
the criterion for statistical significance of associations. All
analyses were conducted using SPSS version 12.0 (SPSS,
Chicago, IL, USA) and STATA version 9.2 (STATA, College
Station, TX, USA). A value of p < 0.05 was considered
statistically significant.
Results
Clinical and radiographic characteristics of
patients
During the study period, 147 adults were diagnosed as having
culture-proven pulmonary TB and all of them agreed to
participate in this observational study. Twelve of the 147
patients were excluded from the analysis because they had
no parenchymal involvement on simple chest radiographs.
No patient was excluded for being anti-HIV antibody posi-
tive. The data from the final 135 patients were analyzed
(Table 1). Of these, 77 (57.0%)weremale and themedian age
of the population was 41 years. Thirty-four (25.2%) patients
had a previous history of TB and 12 patients (8.9%) had
combined extrapulmonary TB. Diabetes was present in 19
patients (14.1%). Approximately half of the patients (61
patients, 45.2%) had an initial sputum smear that showed
acid-fast bacilli, and 114 patients (84.4%) had drug-sensitive
pulmonary TB. After 6 months of anti-TB treatment, three
(2.2%) out of the 135 patients failed to achieve smear
conversion of their sputa. Nodules with patchy opacity
lesions were the most frequent parenchymal disease on
chest radiograph (90 patients, 66.7%) and cavitary lesions
were also common (55 patients, 40.7%). Most of the patients
(120 patients, 88.9%) had multiple parenchymal lesions
(Table 2).
Table 1 Baseline demographic and clinical characteristics
of 135 patients with culture-proven pulmonary tuberculosis
Variable Number
Sex
Male:female 77:58 (57.0%:43.0%)
Age (years), median (range) 41 (18—88)
History of previous TB 34 (25.2%)
History of smoking
Current smoker 33 (24.4%)
Ex-smoker 18 (13.3%)
Never smoker 84 (62.2%)
Body mass indexa (kg/m2) 20.7  2.8
Combined extrapulmonary TB 12 (8.9%)
Underlying medical illness
Diabetes 19 (14.1%)
Chronic renal failure 5 (3.7%)
Chronic liver disease 8 (5.9%)
Malignancy 12 (8.9%)
Immune-suppressed 12 (8.9%)
Underlying lung disease
Asthma 3 (2.2%)
COPD 2 (1.5%)
Bronchiectasis 2 (1.5%)
Othera 6 (4.4%)
AFB smear grade
0 74 (54.8%)
Trace 1 (0.7%)
1 15 (11.1%)
2 12 (8.9%)
3 16 (11.9%)
4 17 (12.6%)
AFB culture grade
<50 45 (33.3%)
1+ 20 (14.8%)
2+ 10 (7.4%)
3+ 25 (18.5%)
4+ 35 (25.9%)
Drug resistance
Sensitive 114 (84.4%)
Resistant, not MDR 11 (8.1%)
MDR 6 (4.4%)
Unavailable 4 (3.0%)
Serum proteinb (mg/dl) 7.2  0.7
Serum albuminb (mg/dl) 3.8  0.5
Serum cholesterolb (mg/dl) 158.2  34.1
Number of leukocytesb
( 109/l)
7.435  2.817
Hemoglobin concentrationb (g/dl) 12.7  2.0
Number of plateletsb ( 109/l) 280  99.6
TB, tuberculosis; COPD, chronic obstructive pulmonary disease;
AFB, acid-fast bacillus; MDR, multidrug-resistant.
Table 2 Radiographic characteristics of 135 patients with
culture-proven pulmonary tuberculosis at the time of initia-
tion of anti-TB medications
Variable Number
Characteristics of parenchymal lesion
Mass-like (>3 cm) 27 (20%)
Nodules with patchy opacity (<3 cm) 90 (66.7%)
Fibrotic 34 (25.2%)
Cavitary 55 (40.7%)
Linear 2 (1.5%)
Miliary 4 (3.0%)
Multiplicity of parenchymal lesion
Single 15 (11.1%)
Multiple 120 (88.9%)
Extent of parenchymal lesiona
At diagnosis 22.8  18.8 (%)
After 6 months of anti-TB treatment 10.5  13.2 (%)
Presence of combined pleural effusion
Right side 13 (9.6%)
Left side 4 (3.0%)
Bilateral 0 (0%)
TB, tuberculosis.
a Average of each parenchymal extent, expressed as mean 
standard deviation.
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At the time of diagnosis, the average extent of radio-
graphic lesions was 22.8%, while the average extent after
6 months of treatment was 10.5% ( p < 0.001). Through
univariate analysis, male sex ( p = 0.029), increasing age
( p = 0.013), previous history of TB ( p < 0.001), multidrug-
resistant TB (MDR-TB; p = 0.003), and presence of cavity
( p = 0.043) and fibrotic lesion on chest radiographs
( p < 0.05) at diagnosis, were significantly associated with
a poor radiographic response. Higher smear grade
( p = 0.005) was also associated in an inverse manner with
radiographic response (Table 3). In a subsequent multiple
regression model, increasing age ( p = 0.034), previous TB
history ( p = 0.016), presence of cavity ( p = 0.016) or fibro-
tic lesion ( p = 0.009) at TB diagnosis, and MDR-TB
( p = 0.002) were significantly associated with a poor radio-
graphic response (Table 4).
Discussion
Although an acid-fast bacillus smear of serial sputa has been
recommended for monitoring treatment response, seriala Four patients had TB-destroyed lung and two patients had
received wedge resections because of mucoepidermoid carci-
noma and giant bulla, respectively.
b Expressed as mean  standard deviation.
Table 3 Univariate analysis for poor radiographic response
b1 95% CI p-Value
Male sex 10.926 20.7, 1.1 0.029
Increasing age 0.343 0.6, 0.075 0.013
History of previous TB 26.34 36.8, 15.8 <0.001
Smoking history (ref.: never smoker) 10.472 21.8, 0.90 0.071
Body mass index 1.021 0.81, 2.9 0.272
Combined extrapulmonary TB 1.079 17.8, 15.7 0.899
Underlying medical illness
Diabetes 5.561 19.8, 8.6 0.44
Chronic renal failure 16.948 9.1, 43.0 0.2
Chronic liver disease 17.048 35.7, 1.6 0.073
Malignancy 11.875 29.1, 5.4 0.176
Immune-suppressed 18.125 1.02, 35.2 0.038
Underlying lung disease (ref.: no disease)
Asthma 1.58 33.82, 30.67 0.92
COPD 34.92 74.25, 4.41 0.08
Bronchiectasis 42.06 81.40, 2.73 0.036
Other 31.93 55.00, 8.86 0.007
Positive AFB smear 8.673 18.5, 1.2 0.084
Smear grade (ref.: grade 0) 4.679 7.9, 1.5 0.005
Smear conversiona (ref.: not converted) 17.389 1.1, 35.9 0.065
Resistance
MDR 34.57 57.3, 11.8 0.003
Resistant, but not MDR 6.216 10.9, 23.3 0.474
Serum protein level 2.912 10.08, 4.26 0.423
Serum albumin level 1.075 8.6, 10.7 0.827
Serum cholesterol level 0.014 0.16, 0.13 0.873
Number of leukocytes 0.001 0.001, 0.002 0.478
Hemoglobin concentration 0.203 2.3, 2.7 0.875
Number of platelets 0.014 0.06, 0.04 0.579
Radiographic characteristics
Mass-like 0.701 11.7, 13.1 0.911
Nodules with patchy opacity 8.177 2.2, 18.5 0.12
Fibrotic 22.26 33.5, 11.0 <0.05
Linear 14.685 55.6, 26.2 0.478
Miliary 24.076 4.8, 53.0 0.102
Presence of cavity 10.281 20.3, 0.3 0.043
Multiplicity 4.519 19.4, 10.3 0.549
CI, confidence interval; TB, tuberculosis; COPD, chronic obstructive pulmonary disease; AFB, acid-fast bacillus; MDR, multidrug-resistant.
a Smear conversion after 6 months of anti-TB treatment. Three patients failed to achieve smear conversion.
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patients who do not produce sputum or in smear-negative
pulmonary TB: at the beginning of treatment, at three
months in the case of culture-negative pulmonary TB, and
at the end of treatment.7 Therefore, the precise interpreta-
tion of various radiographic responses in the context of
treatment response is meaningful. Through this study, we
found that increasing age, previous history of TB, presence of
cavity or fibrotic lesion, and MDR-TB were significantly asso-
ciated with a poor radiographic response.
Host immunity and microbiologic virulence are known to
determine the radiographic characteristics in pulmonaryTB.8—12 Among the various factors affecting host immunity,
increasing age is a well-known factor for a poorer prognosis in
patients with pulmonary TB.11,12 In addition, increasing age
has been reported to be associated with a poor radiographic
response among TB patients.13 Our findings confirm these
previous observations.
In addition, MDR-TB, another clinical factor for the poor
radiographic response in our study, might reflect the poor
prognosis of MDR-TB, per se.14
Given that a fibrotic lesion on chest radiograph at the
beginning of therapy implies that those lesions are already
in an irreversible state, they might not be changed, despite
Table 4 Multivariate analysis for poor radiographic response
b1 T 95% CI p-Value
Age 0.37 2.17 0.70, 0.03 0.034
Male sex 6.15 1.09 5.21, 17.51 0.281
Previous TB history 15.86 2.48 28.68, 3.04 0.016
Presence of cavity 10.85 2.06 21.43, 0.28 0.016
Presence of fibrotic lesion 17.23 2.72 29.98, 4.48 0.009
Miliary TB 32.82 1.71 5.84, 71.47 0.09
Drug resistance (ref: sensitive)
MDR 30.73 9.51 64.29, 98.81 0.002
Resistant, not MDR 3.62 0.43 20.48, 13.25 0.668
CI, confidence interval; TB, tuberculosis; MDR, multidrug-resistant.
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response.13 A fibrotic lesion as a risk factor for poor radio-
graphic response could be understood in this context. In
addition, the fact that a fibronodular lesion is usually seen
among people with a previous history of TB2 might explain a
previous history of TB as a predictor for the poor radio-
graphic response in this study.
Another poor prognostic factor shown by this study was
the presence of cavitary lesions at the beginning of treat-
ment. Cavitation usually results when areas of caseation
necrosis erode the bronchial tree, expelling liquefied debris.
This leads to a continuous supply of well-oxygenated air to
the interior of the cavity, resulting in increased extracellular
bacterial multiplication.15 The size of cavitations and the
number of involved lobes has been reported to be associated
with the number of tuberculous bacilli.15,16 In addition, the
presence of persistent cavity to the end of treatment could
predict a higher rate of future relapse.17 The fact that large
numbers of bacilli might cause more severe parenchymal
destruction and that there is a stronger inflammatory reac-
tion from the intact host immunity in TB patients with
cavities,18,19 might lead to radiographic sequelae being more
prominent.
In conclusion, less prominent radiographic improvement
was common in TB patients with increasing age, a previous
history of TB, MDR-TB, and fibrotic or cavitary lesions in the
chest radiographs at the beginning of therapy. These
patients, if negative tuberculous cultures of their sputa
are sustained, could be closely observed for symptoms and
signs suggesting recurrence of TB, without ordering unne-
cessary chest radiographs or mycobacterial cultures as well
as prolonging treatment.
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